Michał Janowski

5PUBLICATIONS
13CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersReproductive medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 27, 2024
The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity.

Michał Janowski, Karolina Łuczkowska, Michał Gniot

|Jul 28, 2023
High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.

Zuzanna Kanduła, Michał Janowski, Barbara Więckowska

|Oct 20, 2022
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.

Krzysztof Lewandowski, Zuzanna Kanduła, Michał Gniot

|Oct 15, 2022
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.

Zuzanna Kanduła, Michał Janowski, Barbara Więckowska

Pageof 1